Literature DB >> 30473455

Determination of Threshold Scores for Treatment Success After Arthroscopic Rotator Cuff Repair Using Oxford, Constant, and University of California, Los Angeles Shoulder Scores.

Sheng Xu1, Jerry Yongqiang Chen2, Hannah Mei En Lie2, Ying Hao3, Denny Tjiauw Tjoen Lie2.   

Abstract

PURPOSE: To determine the threshold scores for the Constant-Murley score (CMS); University of California, Los Angeles (UCLA) shoulder score; and Oxford Shoulder Score (OSS) that determine treatment success after arthroscopic rotator cuff (RC) repair.
METHODS: Patients who underwent unilateral arthroscopic double-row RC repair by a single surgeon between 2010 and 2015 were prospectively followed up and assessed preoperatively and at 6, 12, and 24 months postoperatively. Perceived pain was measured with a visual analog scale, and functional outcome was assessed by the CMS, UCLA score, and OSS. Treatment success was defined as simultaneous fulfillment of 3 criteria: improvement in pain, expectations for surgery met, and patient satisfied with surgery. Threshold scores were determined by receiver operating characteristic (ROC) analyses, using the various scores as predictors and the defined treatment success as the criterion.
RESULTS: The study included a total of 214 patients (96 male and 118 female patients) with a mean age of 60.1 ± 10 years. Most patients showed improvement in pain (≥88%) and high satisfaction (≥93%) and expectation fulfillment (≥80%) postoperatively. Of the patients, 73% had treatment success at 6 months; 85%, at 12 months; and 80%, at 24 months. ROC analyses showed good prediction of treatment success using the CMS, UCLA score, and OSS at all 3 follow-up time points (area under the ROC curve [AUC] > 0.70), with excellent prediction using the UCLA score at 12 months and 24 months (AUC, 0.811 and 0.805, respectively) and the OSS at 12 months (AUC, 0.820). The following threshold scores were identified: CMS of 59, UCLA score of 21, and OSS of 42 at 6 months; CMS of 61, UCLA score of 26, and OSS of 43 at 12 months; and CMS of 65, UCLA score of 30, and OSS of 46 at 24 months.
CONCLUSIONS: The CMS, UCLA score, and OSS have good predictive value in defining treatment success after arthroscopic RC repair. The cutoff scores are time dependent. LEVEL OF EVIDENCE: Level II, development of diagnostic criteria.
Copyright © 2019 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30473455     DOI: 10.1016/j.arthro.2018.07.047

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  4 in total

1.  Patch augmentation surgery for rotator cuff repair: the PARCS mixed-methods feasibility study.

Authors:  Jonathan A Cook; Mathew Baldwin; Cushla Cooper; Navraj S Nagra; Joanna C Crocker; Molly Glaze; Gemma Greenall; Amar Rangan; Lucksy Kottam; Jonathan L Rees; Dair Farrar-Hockley; Naomi Merritt; Sally Hopewell; David Beard; Michael Thomas; Melina Dritsaki; Andrew J Carr
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

2.  Threshold scores for treatment success after arthroscopic bankart repair using Oxford Shoulder Instability Score, Constant-Murley Score, and UCLA shoulder score.

Authors:  Sheng Xu; Jerry Yongqiang Chen; Ying Hao; Chee Cheng Paul Chang; Denny Tjiauw Tjoen Lie
Journal:  J Orthop       Date:  2020-05-07

3.  The UCLA Shoulder Score Is a Better Predictor of Treatment Success Than the Constant and Oxford Shoulder Scores After Arthroscopic Rotator Cuff Repair: A 2-Year Follow-Up Study.

Authors:  Vikaesh Moorthy; Jerry Yongqiang Chen; Merrill Lee; Benjamin Fu Hong Ang; Denny Tjiauw Tjoen Lie
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-02-25

4.  Use of implantable meshes for augmented rotator cuff repair: a systematic review and meta-analysis.

Authors:  Mathew Baldwin; N S Nagra; Gemma Greenall; Andrew J Carr; David Beard; J L Rees; Amar Rangan; Naomi Merritt; Melina Dritsaki; Sally Hopewell; Jonathan Alistair Cook
Journal:  BMJ Open       Date:  2020-12-07       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.